Table 3.
Amount and content of corresponding nitrosamine detected in positive samples.
| Item | NDMA | NDEA | NMBA | NMOR | NPIP | |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
||||||
| Amounta (pcs) | Content (μg/g) | Amount (pcs) | Content (μg/g) | Amount (pcs) | Content (μg/g) | Amount (pcs) | Content (μg/g) | Amount (pcs) | Content (μg/g) | |
| Valsartan | 53 | 0.10–137.60 | 11 | 0.07–6.90 | 1 | 0.14 | 2 | 0.16 | 2 | 0.12 |
| Losartan | 0 | ND | 4 | 0.08–0.23 | 32 | 0.22–27.40 | 0 | ND | 0 | ND |
| Irbesartan | 0 | ND | 5 | 0.11–0.12 | 0 | ND | 0 | ND | 0 | ND |
a
Amount of contaminated samples sorted according to corresponding nitrosamine.